Article thumbnail

Initial Mutations Direct Alternative Pathways of Protein Evolution

By Merijn L. M. Salverda, Eynat Dellus, Florien A. Gorter, Alfons J. M. Debets, John van der Oost, Rolf F. Hoekstra, Dan S. Tawfik and J. Arjan G. M. de Visser

Abstract

Whether evolution is erratic due to random historical details, or is repeatedly directed along similar paths by certain constraints, remains unclear. Epistasis (i.e. non-additive interaction between mutations that affect fitness) is a mechanism that can contribute to both scenarios. Epistasis can constrain the type and order of selected mutations, but it can also make adaptive trajectories contingent upon the first random substitution. This effect is particularly strong under sign epistasis, when the sign of the fitness effects of a mutation depends on its genetic background. In the current study, we examine how epistatic interactions between mutations determine alternative evolutionary pathways, using in vitro evolution of the antibiotic resistance enzyme TEM-1 β-lactamase. First, we describe the diversity of adaptive pathways among replicate lines during evolution for resistance to a novel antibiotic (cefotaxime). Consistent with the prediction of epistatic constraints, most lines increased resistance by acquiring three mutations in a fixed order. However, a few lines deviated from this pattern. Next, to test whether negative interactions between alternative initial substitutions drive this divergence, alleles containing initial substitutions from the deviating lines were evolved under identical conditions. Indeed, these alternative initial substitutions consistently led to lower adaptive peaks, involving more and other substitutions than those observed in the common pathway. We found that a combination of decreased enzymatic activity and lower folding cooperativity underlies negative sign epistasis in the clash between key mutations in the common and deviating lines (Gly238Ser and Arg164Ser, respectively). Our results demonstrate that epistasis contributes to contingency in protein evolution by amplifying the selective consequences of random mutations

Topics: Research Article
Publisher: Public Library of Science
OAI identifier: oai:pubmedcentral.nih.gov:3048372
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2010). A
  2. (1991). A standard numbering scheme for the class-A b-lactamases.
  3. (1997). Cephalosporin substrate specificity determinants of TEM-1 b-lactamase.
  4. (2006). Darwinian evolution can follow only very few mutational paths to fitter proteins.
  5. (2000). Detrimental effect of the combination of R164S with G238S in TEM-1 blactamase on the extended-spectrum activity conferred by each single mutation.
  6. (1999). Different trajectories of parallel evolution during viral adaptation.
  7. (1994). Effect of Threonine-toMethionine substitution at position 265 on structure and function of TEM-1 blactamase.
  8. (2007). Empirical fitness landscapes reveal accessible evolutionary paths.
  9. (1985). Enzyme Structure and Mechanism.New
  10. (2003). Experimental prediction of the natural evolution of antibiotic resistance.
  11. (1995). Experimental tests of the roles of adaptation, chance, and history in evolution.
  12. (2009). Exploring the effect of sex on empirical fitness landscapes.
  13. (2008). Historical contingency and the evolution of a key innovation in an experimental population of Escherichia coli.
  14. (2008). Increased folding stability of TEM-1 b-lactamase by in vitro selection.
  15. (2008). Intense neutral drifts yield robust and evolvable consensus proteins.
  16. (2002). Long-term experimental evolution in Escherichia coli. XI. Rejection of non-transitive interactions as cause of declining rate of adaptation.
  17. (2005). Missense meanderings in sequence space: a biophysical view of protein evolution.
  18. (2007). Mitotic recombination accelerates adaptation in the fungus Aspergillus nidulans.
  19. (2001). Multidimensional epistasis and the disadvantage of sex.
  20. (2010). Multiple global suppressors of protein stability defects facilitate the evolution of extendedspectrum TEM b-lactamases.
  21. (1990). Mutational order - a major stochastic process in evolution.
  22. (2010). Natural evolution of TEM1 b-lactamase: experimental reconstruction and clinical relevance.
  23. (1978). Nucleotide sequence of ampicillin resistance gene of Escherichia coli plasmid pBR322.
  24. (2009). Parallel genetic evolution within and between bacteriophage species of varying degrees of divergence.
  25. (2005). Parallel genotypic adaptation: when evolution repeats itself.
  26. (2005). Perspective: sign epistasis and genetic constraint on evolutionary trajectories.
  27. (2002). Predicting evolution by in vitro evolution requires determining evolutionary pathways.
  28. (2002). Predicting evolutionary potential: in vitro evolution accurately reproduces natural evolution of the TEM b-lactamase.
  29. (2001). Predicting the emergence of antibiotic resistance by directed evolution and structural analysis.
  30. (2005). Rapid evolutionary escape by large populations from local fitness peaks is likely in nature.
  31. (2006). Robustnessepistasis link shapes the fitness landscape of a randomly drifting protein.
  32. (1998). Selection and characterization of b-lactam-b-lactamase inactivator-resistant mutants following PCR mutagenesis of the TEM-1 b-lactamase gene.
  33. (2010). Sequence space and the ongoing expansion of the protein universe.
  34. (2005). Statistics of protein library construction.
  35. (2005). Structural perturbation and compensation by directed evolution at physiological temperature leads to thermostabilization of blactamase.
  36. Tawfik DS (2009) Stability effects of mutations and protein evolvability.
  37. (2006). Tests of parallel molecular evolution in a long-term experiment with Escherichia coli.
  38. (1999). The effect of high-frequency random mutagenesis on in vitro protein evolution: a study on TEM-1 b-lactamase.
  39. (2010). The rate of fitness-valley crossing in sexual populations.